Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutropin AQ in Children with MPS I, II, and VI
NCT00748969Phase 3Terminated
- Sponsor
- The Lundquist Institute
- Start
- Nov 2008
- Primary completion
- Sep 2013
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of somatropin in mucopolysaccharidosis type I, mucopolysaccharidosis type II and mucopolysaccharidosis type VI (2 arms), sponsored by The Lundquist Institute. Primary endpoint: Change in Growth Velocity From Baseline to End of Study Year 1. Started Nov 2008; status: terminated.
02
Drugs
somatropin
03
Conditions
mucopolysaccharidosis type Imucopolysaccharidosis type IImucopolysaccharidosis type VI
Beyond the preview
Go deeper on NCT00748969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748969.